3-Methylcrotonylglycinuria I/II : MCCC1/MCCC2 Sequencing

Test Information

MCCC1/MCCC2 sequencing is a molecular test used to identify variants in the genes associated with 3-Methylcrotonylglycinuria.

Turnaround Time

2 weeks

CPT Code(s)

81406 x 2

Cost

$2,000

Genes

Clinical Information

3-Methylcrotonylglycinuria (3MCC) is an autosomal recessive inborn error of leucine metabolism caused by the deficiency of 3-methylcrotonyl-CoA carboxylase. Patients are often identified through newborn screening. Mildly affected or asymptomatic mothers with 3MCC deficiency have also been identified through positive newborn screening in their children. The presentation of this disorder is highly variable with severe cases experiencing significant neurological abnormalities, psychomotor retardation, seizures, cardio-respiratory failure and coma. Ketoacidosis, hypoglycemia and hyperammonemia are often seen. Mild cases may be asymptomatic or display fatigue, muscle weakness and/or mild developmental delay. 3MCC can be caused by a mutation in either the gene coding the alpha subunit (MCCC1) or the beta subunit (MCCC2) of the enzyme.

Indications

Molecular testing is useful to confirm the diagnosis and to identify the disease causing mutations within a family to allow for carrier testing and prenatal diagnosis.

Methodology

Sanger Sequencing

Detection

Sequencing of the MCCC1 and MCCC2 genes will detect mutations in 99% of individuals with 3MCC.

Specimen Requirements

5 to 7 ml of peripheral blood collected in an EDTA (lavender top) tube is the preferred specimen type. The minimal blood needed for reliable DNA isolation is 3 ml. Extracted DNA, dried blood spots, and saliva are also accepted for this test.

Transport Instructions

The specimen should be kept at room temperature and delivered via overnight shipping. If shipment is delayed by one or two days, the specimen should be refrigerated and shipped at room temperature. Do not freeze the specimen. Samples collected on Friday can be safely designated for Monday delivery.

Prenatal Testing Information

Prenatal diagnosis is available if the familial mutations are known. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen.

Have Questions Need Support?

Call our laboratory at 1-800-473-9411 or contact one of our Laboratory Genetic Counselors for assistance.
Robin Fletcher, MS, CGC
Kellie Walden, MS, CGC

Molecular Testing, Newborn Screening Follow-Up, Sanger Sequencing
Meet Reggie Roper

Meet Reggie Roper

Reggie has been part of the GGC family for over 18 years. He has short stature, webbing of his hands, pulmonary stenosis, seizures and hydrocephalus along with developmental delay. He carried an initial diagnosis of cardiofaciocutaneous (CFC) syndrome; however, as genetic testing advanced, GGC made the diagnosis of Noonan-like syndrome with loose anagen hair by identifying a mutation in the SHOC2 gene. He is also an active participant in the Greenwood Community Theatre's Penguin Project. "GGC is...

In The News